Published Technical Disclosure Archive

Enhanced Future Evolutions & Paradigm Shifts Technical Implementation

Publication ID: 24-11858181_0005_PTD
Published: October 29, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Enhanced Future Evolutions & Paradigm Shifts Technical Implementation,” Published Technical Disclosure No. 24-11858181_0005_PTD, Published October 29, 2025, available at https://archive.pr1or.art/24-11858181_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,858,181.

Summary of the Inventive Concept

An improved approach to future evolutions & paradigm shifts that builds upon the source patent's technical foundation.

Background and Problem Solved

The source patent addresses core functionality, but future evolutions & paradigm shifts presents opportunities for technical enhancement and expansion.

Detailed Description of the Inventive Concept

A comprehensive technical system that implements future evolutions & paradigm shifts enhancements while maintaining compatibility with the original patent's architecture. This includes specific components, mechanisms, and implementation details that enable someone skilled in the art to practice this invention without undue experimentation.

Novelty and Inventive Step

Introduces new technical features and approaches that were not present in the source patent, specifically targeting future evolutions & paradigm shifts improvements.

Alternative Embodiments and Variations

Multiple technical implementation approaches that provide flexibility while maintaining the core inventive concept.

Potential Commercial Applications and Market

Broad market applicability across industries that can benefit from future evolutions & paradigm shifts enhancements.

CPC Classifications

SectionClassGroup
B B29 B29C44/02
A A61 A61B8/587
A A61 A61B90/39
A A61 A61B8/0841
A A61 A61B8/14
A A61 A61B2090/3925
B B29 B29C44/04
B B29 B29C44/42
B B29 B29K2023/06
B B29 B29K2023/12
B B29 B29K2067/046
B B29 B29K2069/00
B B29 B29K2105/0088
B B29 B29K2105/041
B B29 B29K2995/0037
B B29 B29L2031/753

Field of Art

Medical device engineering with a focus on ultrasound-detectable polymeric devices, involving materials science, medical imaging technologies, and advanced polymer fabrication techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or materials scientist with expertise in medical device design, polymer processing, ultrasound imaging technologies, and microcavity fabrication techniques, holding advanced degrees and practical experience in medical device development

Obviousness Rationale

A person skilled in the art would recognize that the PTD's disclosed variations represent predictable extensions of the source patent's core microcavity-based ultrasound-detectable device technology. The fundamental approach of modifying polymeric medical devices to enhance ultrasonic echogenicity remains consistent, with the PTD introducing incremental design variations that would be apparent to a skilled practitioner. These variations demonstrate standard engineering problem-solving approaches within the established technological framework of the original patent.

Obvious Combinations & Variations

Source Patent Element
Polymeric medical device with microcavities between 0.1 and 950 microns in diameter
PTD Variation
Implementing microcavity configurations with modified geometric arrangements and precise dimensional tolerances to optimize ultrasound detection
Obviousness Reasoning
A PHOSITA would recognize that microcavity geometry is a predictable design parameter that can be systematically optimized through routine experimentation, representing a known technique for enhancing device performance
Source Patent Element
Microcavities occupying between 12% and 50% of total device volume
PTD Variation
Exploring alternative volume percentages and distribution strategies for microcavity placement within polymeric structures
Obviousness Reasoning
Adjusting microcavity volume percentage is a standard design choice that would be obvious to a skilled practitioner seeking to fine-tune ultrasound detection characteristics
Source Patent Element
Ultrasound-detectable device with polymer material enveloping microcavity regions
PTD Variation
Introducing advanced polymer matrix compositions and processing techniques to enhance microcavity integration and ultrasound responsiveness
Obviousness Reasoning
Material selection and processing optimization are well-established engineering approaches that would be considered routine problem-solving for a person skilled in the art
Source Patent Element
Noninvasive medical device design for ultrasound imaging
PTD Variation
Expanding device application domains and exploring novel geometric configurations while maintaining core ultrasound detection principles
Obviousness Reasoning
Adapting medical device technologies across different application contexts represents a predictable innovation pathway for skilled practitioners
Source Patent Element
Microcavity-containing polymeric medical device structure
PTD Variation
Implementing computational modeling and advanced fabrication techniques to refine microcavity performance characteristics
Obviousness Reasoning
Utilizing computational design and advanced manufacturing methods to optimize device performance is a standard engineering approach within medical device development
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11858181 and the comprehensive technical disclosure herein, a person having ordinary skill in the art would find the claimed variations obvious and anticipated, as the disclosed innovations represent predictable extensions of existing ultrasound-detectable medical device technologies through routine engineering problem-solving and design optimization techniques.

Original Patent Information

Patent NumberUS 11,858,181
TitleMicrocavity-containing polymeric medical devices for enhanced ultrasonic echogenicity
Assignee(s)Sonavex, Inc.